Active substances
Dextromethorphan + Guaifenesin + Pseudoephedrine
- SFDA 2
- Health Canada 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ROBITUSSIN CF SYRUP | 100,30,10 mg,mg,mg | Syrup · Oral use | 1 Bottle | SAR 8.80 | NCE · Prescription | PFIZER INC | Valid |
| ROBITUSSIN CF SYRUP | 100, 10, 30 mg | Syrup · Oral use | 1 Bottle | SAR 8.80 | NCE · Prescription | FEREVA RICHMOND | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION | 02003317 | 15 MG / 5 ML; 200 MG / 5 ML; 30 MG / 5 ML | SYRUP · ORAL | KENVUE CANADA INC. |
| COUGH & COLD RELIEF EXTRA STRENGTH | 02540800 | 15 MG / 5 ML; 30 MG / 5 ML; 200 MG / 5 ML | SYRUP · ORAL | CRLS |
| ROBITUSSIN EXTRA STRENGTH COUGH & COLD | 02172380 | 30 MG / 5 ML; 15 MG / 5 ML; 200 MG / 5 ML | SYRUP · ORAL | HALEON CANADA ULC |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.